Sylvia Cheng

987 total citations
34 papers, 280 citations indexed

About

Sylvia Cheng is a scholar working on Genetics, Neurology and Surgery. According to data from OpenAlex, Sylvia Cheng has authored 34 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 14 papers in Neurology and 7 papers in Surgery. Recurrent topics in Sylvia Cheng's work include Glioma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (10 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Sylvia Cheng is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (10 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Sylvia Cheng collaborates with scholars based in Canada, United States and United Kingdom. Sylvia Cheng's co-authors include Ute Bartels, Lillian Sung, Éric Bouffet, Normand Laperrière, John‐Paul Kilday, Laura Janzen, Ran D. Goldman, James M. Drake, D. Douglas Cochrane and Oliver Teuffel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Epidemiology and British Journal of Cancer.

In The Last Decade

Sylvia Cheng

24 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Cheng Canada 9 130 67 66 61 61 34 280
Maisa Swaidan Jordan 11 141 1.1× 34 0.5× 62 0.9× 85 1.4× 57 0.9× 18 351
Revathi Rajagopal Malaysia 10 116 0.9× 29 0.4× 80 1.2× 46 0.8× 30 0.5× 24 266
Laura Simon United States 11 37 0.3× 130 1.9× 74 1.1× 56 0.9× 37 0.6× 22 366
Yeon Jung Lim South Korea 12 42 0.3× 68 1.0× 44 0.7× 43 0.7× 40 0.7× 38 289
Ravi Dadlani India 9 106 0.8× 110 1.6× 65 1.0× 25 0.4× 19 0.3× 33 293
Carla Golden United States 7 78 0.6× 24 0.4× 55 0.8× 68 1.1× 39 0.6× 15 264
T.Z. Vern-Gross United States 11 84 0.6× 138 2.1× 37 0.6× 178 2.9× 95 1.6× 40 404
Andrés Gómez‐De León Mexico 12 84 0.6× 31 0.5× 20 0.3× 30 0.5× 86 1.4× 96 436
Augustina Ogbonnaya United States 13 55 0.4× 47 0.7× 37 0.6× 17 0.3× 97 1.6× 48 371
Emily Livesey United Kingdom 6 67 0.5× 209 3.1× 49 0.7× 160 2.6× 24 0.4× 10 349

Countries citing papers authored by Sylvia Cheng

Since Specialization
Citations

This map shows the geographic impact of Sylvia Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Cheng more than expected).

Fields of papers citing papers by Sylvia Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Cheng. The network helps show where Sylvia Cheng may publish in the future.

Co-authorship network of co-authors of Sylvia Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Cheng. A scholar is included among the top collaborators of Sylvia Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Cheng. Sylvia Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cheng, Sylvia, et al.. (2025). What Have We Learnt from the Recent Multimodal Managements of Young Patients with ATRT?. Cancers. 17(7). 1116–1116.
3.
Hazrati, Lili‐Naz, et al.. (2024). HGG-10. YAP1-MAML2 FUSION IN YOUNG CHILDREN WITH PEDIATRIC HIGH-GRADE GLIOMA: A CASE REPORT. Neuro-Oncology. 26(Supplement_4). 0–0.
5.
Ronsley, Rebecca, Joanna Triscott, Joseph Stanek, et al.. (2023). Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review. Child s Nervous System. 39(8). 2095–2104. 3 indexed citations
6.
Lindsay, Holly, Sylvia Cheng, Paul G. Fisher, et al.. (2023). Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group. Neuro-Oncology Advances. 5(1). vdad130–vdad130. 1 indexed citations
8.
Erker, Craig, Sylvia Cheng, Kathryn McFadden, et al.. (2022). MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation ofBRAFV600E Mutation,BRAFFusion, and Wild-Type Tumors in Patients without Neurofibromatosis-1. American Journal of Neuroradiology. 43(8). 1196–1201. 6 indexed citations
9.
Plant, Ashley, Rosdali Díaz Coronado, Sidnei Epelman, et al.. (2022). An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry. Journal of Neuro-Oncology. 159(3). 563–570.
10.
Cheng, Sylvia, Michael Coccia, Catherine J. Karr, et al.. (2022). Associations Between Maternal Stressful Life Events and Perceived Distress during Pregnancy and Child Mental Health at Age 4. Research on Child and Adolescent Psychopathology. 50(8). 977–986. 7 indexed citations
11.
Freeman, Carolyn, et al.. (2022). Proton Therapy in Canada: Toward Universal Access and Health Equity With a Publicly Funded Facility. International Journal of Radiation Oncology*Biology*Physics. 116(2). 394–403. 4 indexed citations
12.
Wong, Jordan, Karen Goddard, Normand Laperrière, et al.. (2020). Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults. Journal of Neuro-Oncology. 149(3). 523–532. 15 indexed citations
13.
Cheng, Sylvia, et al.. (2020). Anaphylaxis to parenteral nutrition in a pediatric oncology patient treated with induction of drug tolerance protocol. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 553–554.
14.
Lo, Andrea, David Hodgson, Scott Tyldesley, et al.. (2019). Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes. International Journal of Radiation Oncology*Biology*Physics. 106(2). 269–278. 28 indexed citations
15.
Lo, Andrea, Normand Laperrière, David Hodgson, et al.. (2019). Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adults. Journal of Neuro-Oncology. 143(2). 289–296. 7 indexed citations
16.
Cheng, Sylvia, John‐Paul Kilday, Normand Laperrière, et al.. (2016). Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation. Journal of Neuro-Oncology. 127(1). 173–180. 54 indexed citations
17.
Cheng, Sylvia, Cynthia Hawkins, Michael D. Taylor, & Ute Bartels. (2015). Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin. Pediatric Neurology. 53(3). 238–242.e1. 7 indexed citations
18.
Sung, Lillian, Shabbir M.H. Alibhai, Marie‐Chantal Ethier, et al.. (2012). Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia. Journal of Clinical Epidemiology. 65(6). 627–634. 15 indexed citations
19.
Teuffel, Oliver, Sylvia Cheng, M.C. Ethier, et al.. (2012). Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients. Supportive Care in Cancer. 20(11). 2755–2764. 22 indexed citations
20.
Chang, C. S., Sylvia Cheng, & H.H. Dijkstra. (2011). Note on the type series of Parvamussium liaoi and Scaeochlamys squamea (Bivalvia: Pectinoidea) from Taiwan. 8. 7–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026